FDA import alert
Import Alert 66-80
Detention Without Physical Examination of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Bulk Drug Substances
0
Red-list entries
0
Green-list entries
0
Countries
10/09/2026
Last change seen
What being on this list means
Firms on an import alert's Red List are subject to Detention Without Physical Examination (DWPE): FDA can detain their shipments at the border automatically, without sampling or inspecting them. The burden shifts to the importer to prove — typically with private laboratory analysis, shipment by shipment — that the goods are not violative. Removal from the list requires evidence that the underlying problem is resolved, usually including a track record of consecutive clean shipments and a petition to FDA. How removal works →
A Green List on a countrywide alert works the other way: it names the firms FDA has excluded from detention because they demonstrated compliance.
Is your supplier on this alert?
Review the firms below and verify each match on the official FDA source. Watch subscriptions and automated email alerts are not available to start.
Does this alert touch your supply chain? Check monitoring availability →